|
MED8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.119600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.957000E-01 |
| Normal-vs-Stage2 |
8.854000E-01 |
| Normal-vs-Stage3 |
1.264330E-02 |
| Normal-vs-Stage4 |
4.440300E-03 |
| Stage1-vs-Stage2 |
8.433000E-01 |
| Stage1-vs-Stage3 |
2.527700E-02 |
| Stage1-vs-Stage4 |
8.096200E-03 |
| Stage2-vs-Stage3 |
7.501700E-02 |
| Stage2-vs-Stage4 |
3.829800E-02 |
| Stage3-vs-Stage4 |
4.546200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.683800E-02 |
| Normal-vs-AfricanAmerican |
6.737400E-01 |
| Normal-vs-Asian |
3.565500E-02 |
| Caucasian-vs-AfricanAmerican |
7.630000E-01 |
| Caucasian-vs-Asian |
4.333400E-01 |
| AfricanAmerican-vs-Asian |
4.463400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.295800E-01 |
| Normal-vs-Female |
2.929600E-01 |
| Male-vs-Female |
7.794200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.981400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.269400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.149810E-02 |
| Normal-vs-Age(81-100Yrs) |
5.974200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.659400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.437700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.889000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.954600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.642400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.654620E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.14439999999261E-05 |
| Classical-VS-Follicular |
1.098020E-02 |
| Classical-VS-Other |
8.887800E-01 |
| Classical-VS-Normal |
1.038820E-01 |
| Tall-VS-Follicular |
6.20030000009208E-07 |
| Tall-VS-Other |
2.805200E-01 |
| Tall-VS-Normal |
1.33799999968431E-07 |
| Follicular-VS-Other |
3.608800E-01 |
| Follicular-VS-Normal |
1.063370E-01 |
| Other-VS-Normal |
5.497600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.513200E-01 |
| Normal-vs-N1 |
1.004670E-03 |
| N0-vs-N1 |
1.923120E-03 |
|
|
